Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shengshi Baicao, also referred to in English as CHINA MEDICO CORPORATION, is a China-based traditional Chinese medicine company focused on standardized cultivation of medicinal herbs, production of crude herbs and decoction pieces, and related biopharmaceutical technology development. The company operates an integrated supply chain spanning cultivation, sourcing, processing, testing, warehousing, and commercialization, with large standardized planting bases and a processing center in Tianjin designed to PIC/S GMP norms. Its business is centered on commercialized herbal raw materials and decoction-piece products rather than a conventional innovative drug pipeline. The company has emphasized quality traceability, CNAS-certified testing, export capabilities, and collaborations with major Chinese and Japanese traditional medicine research institutions. It was acquired/restructured through strategic investment by Pingan Jincun and appears to remain an operating business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shengshi Baicao.